MichaelE.RyttingMD
Pediatric Hematology & Oncology • Holland, MIAssociate Professor, Pediatrics and Leukemia
Dr. Rytting is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3235 N Wellness Dr
Ste 120A
Holland, MI 49424Phone+1 616-399-0902Fax+1 616-399-0513- Is this information wrong?
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Pediatric Hematology/Oncology, 1994 - 1997- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1990 - 1994
University of Michigan Medical SchoolClass of 1990
Certifications & Licensure
MI State Medical License 1993 - 2026
TX State Medical License 1994 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Treatment of Tumors of the Choroid Plexus Epithelium Start of enrollment: 2005 Sep 02
- Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma Start of enrollment: 2006 Sep 12
- Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma Start of enrollment: 2009 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 53 citationsAutologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia.Francesco Paolo Tambaro, Harjeet Singh, Emily Jones, Michael Rytting, Kris M. Mahadeo, Philip A. Thompson, Naval Daver, Courtney D. DiNardo, Tapan M. Kadia, Guillermo ...> ;Leukemia. 2021 Apr 8
- 5 citationsUse of pegylated interferon in young patients with polycythemia vera and essential thrombocythemiaNicole Kucine, Shayla Bergmann, Spencer Krichevsky, Devin Jones, Michael Rytting, Juhi Jain, Carolyn M. Bennett, Linda M.S. Resar, John Mascarenhas, Srdan Verstovsek, ...> ;Pediatric Blood & Cancer. 2021 Mar 1
- 7 citationsVenetoclax and Decitabine in Pediatric Refractory T-cell Lymphoblastic Lymphoma.Muhammad Baig, Michael Rytting, Michael Roth, Ajaykumar C. Morani, Cesar Nunez, Pei Lin, Branko Cuglievan> ;Journal of Pediatric Hematology/oncology. 2021 Oct 1
- Join now to see all
Abstracts/Posters
- Outcomes of Relapsed or Refractory Acute Myeloid Leukemia after Frontline Hypomethylating Agent with Venetoclax RegimensMichael E. Rytting, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Outcomes in Molecular Subgroups and Resistance Patterns with Ten-Day Decitabine and Venetoclax (DEC10-VEN) in Acute Myeloid LeukemiaMichael E. Rytting, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Prognostic Significance of IKZF1, PAX5, and CDKN2A Deletions in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Hyper-CVAD/MA ...Michael E. Rytting, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Other Languages
- Spanish
Hospital Affiliations
- Holland HospitalHolland, Michigan
- El Paso Children's HospitalEl Paso, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
